Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2024 Filed Nov 25, 2024 14:05 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionCommon Stock | 12,800 | $91.07 | $1,165,696.00 |
DisclosureSEC source: 0001127602-24-027949 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,395.4304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 15, 2024 Filed Nov 25, 2024 14:05 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 4.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-027949 · form4.xml · derivative · entry 4 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.7797 Underlying: Common Stock · 4.8 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 2, 2024 15:08 UTC |
Coombe Gary ACEO - Grooming
|
GrantRestricted Stock Units · Derivative | 46.1626 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-028234 · form4.xml · derivative · entry 5 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900.6351 Underlying: Common Stock · 46.1626 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 17:47 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantRestricted Stock Units · Derivative | 21.6833 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029843 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157.7264 Underlying: Common Stock · 21.6833 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 17:48 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantRestricted Stock Units · Derivative | 184.574 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029844 · form4.xml · derivative · entry 7 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,007.3245 Underlying: Common Stock · 184.574 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 17:50 UTC |
Schulten AndreChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 19.7668 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029845 · form4.xml · derivative · entry 4 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121.4685 Underlying: Common Stock · 19.7668 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 17:53 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 30.2281 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029847 · form4.xml · derivative · entry 6 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 489.601 Underlying: Common Stock · 30.2281 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 17:54 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 6.1063 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029848 · form4.xml · derivative · entry 4 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21.2081 Underlying: Common Stock · 6.1063 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 17:56 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 19.8521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029849 · form4.xml · derivative · entry 4 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150.214 Underlying: Common Stock · 19.8521 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 17:58 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 200.7909 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029850 · form4.xml · derivative · entry 8 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,080.245 Underlying: Common Stock · 200.7909 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 18:17 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantRestricted Stock Units · Derivative | 43.4378 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029851 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 626.3542 Underlying: Common Stock · 43.4378 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 18:29 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantRestricted Stock Units · Derivative | 11.5129 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029852 · form4.xml · derivative · entry 6 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73.3824 Underlying: Common Stock · 11.5129 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2024 Filed Aug 7, 2025 18:59 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 53.4928 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000089 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 884.0278 Underlying: Common Stock · 53.4928 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| October 24, 2024 Filed Oct 25, 2024 14:52 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,800 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-24-025963 · form4.xml · derivative · entry 4 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,627 Underlying: Common Stock · 12,800 shares Expires 2027-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2024 Filed Oct 25, 2024 14:52 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 12,800 | $168.99 | $2,163,008.00 |
DisclosureSEC source: 0001127602-24-025963 · form4.xml · nonDerivative · entry 2 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,565.9989 Read SEC document |
| October 24, 2024 Filed Oct 25, 2024 14:52 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionCommon Stock | 12,800 | $91.07 | $1,165,696.00 |
DisclosureSEC source: 0001127602-24-025963 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,365.9989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2024 Filed Oct 24, 2024 20:28 UTC |
Keith R. AlexandraCEO - Beauty
|
OtherCommon Stock | 479.1333 | $169.49 | $81,207.06 |
DisclosureSEC source: 0001127602-24-025910 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse, By Retirement Plan Trustee Disclosed balance after: 2,042.6208 Read SEC document |
| October 23, 2024 Filed Oct 24, 2024 20:28 UTC |
Keith R. AlexandraCEO - Beauty
|
OtherCommon Stock | 886.7556 | $169.49 | $150,293.90 |
DisclosureSEC source: 0001127602-24-025910 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Retirement Plan Trustee Disclosed balance after: 3,780.3792 Read SEC document |
| October 22, 2024 Filed Oct 23, 2024 17:36 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 409 | $170.00 | $69,530.00 |
DisclosureSEC source: 0001127602-24-025874 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 3,487.9748 Read SEC document |
| October 22, 2024 Filed Oct 23, 2024 17:36 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,992 | $170.00 | $338,640.00 |
DisclosureSEC source: 0001127602-24-025874 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,783.1608 Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 15:58 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025350 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,051.9845 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 15:59 UTC |
Biggs M. BrettDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025351 · form4.xml · nonDerivative · entry 1 Biggs M. Brett · CIK 0001662848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,561.5285 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:00 UTC |
Bonini SheilaDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025352 · form4.xml · nonDerivative · entry 1 Bonini Sheila · CIK 0001973331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866.2186 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:02 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025353 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,463.5277 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:03 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025354 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,245.5316 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:04 UTC |
LEE DEBRA LDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025355 · form4.xml · nonDerivative · entry 1 LEE DEBRA L · CIK 0001119838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,599.9199 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total Includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:05 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025356 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,518.8003 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:07 UTC |
McEvoy AshleyDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025357 · form4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,082.6443 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:08 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025358 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,153.6365 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:09 UTC |
Subramaniam RajeshDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025359 · form4.xml · nonDerivative · entry 1 Subramaniam Rajesh · CIK 0001679607 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,557.5067 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:10 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025360 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,583.2319 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 16:12 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025361 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,712.1456 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 18:06 UTC |
Chang AmyDirector
|
GrantCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025363 · form4.xml · nonDerivative · entry 1 Chang Amy · CIK 0001551504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,097.7453 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 16:26 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,678 | $170.99 | $286,921.05 |
DisclosureSEC source: 0001127602-24-025230 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,775.1608 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 16:26 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 345 | $170.99 | $58,991.52 |
DisclosureSEC source: 0001127602-24-025230 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 3,896.9748 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:24 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 1,569 | $171.65 | $269,325.28 |
DisclosureSEC source: 0001127602-24-025119 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,639.2045 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:26 UTC |
Davis Jennifer L.CEO - Health Care
|
SaleCommon Stock | 4,447 | $171.65 | $763,345.78 |
DisclosureSEC source: 0001127602-24-025122 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,872.0851 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit Award. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:27 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 7,007 | $171.65 | $1,202,780.28 |
DisclosureSEC source: 0001127602-24-025123 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,171.8949 F2 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:29 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 634 | $171.65 | $108,828.70 |
DisclosureSEC source: 0001127602-24-025124 · form4.xml · nonDerivative · entry 2 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,341.1201 F2 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 19:48 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantStock Option (Right to Buy) · Derivative | 57,601 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025065 · form4.xml · derivative · entry 3 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,601 Underlying: Common Stock · 57,601 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 19:49 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 31,659 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025067 · form4.xml · derivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,659 Underlying: Common Stock · 31,659 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 19:52 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,775 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025069 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,775 Underlying: Common Stock · 42,775 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 19:58 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantStock Option (Right to Buy) · Derivative | 55,670 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025071 · form4.xml · derivative · entry 4 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,670 Underlying: Common Stock · 55,670 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:00 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 12,183 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025072 · form4.xml · derivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 12,183 Underlying: Common Stock · 12,183 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:00 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 55,670 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025072 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,670 Underlying: Common Stock · 55,670 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,087 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025073 · form4.xml · derivative · entry 3 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,087 Underlying: Common Stock · 12,087 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 94,338 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025074 · form4.xml · derivative · entry 5 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,338 Underlying: Common Stock · 94,338 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC |
Coombe Gary ACEO - Grooming
|
GrantStock Option (Right to Buy) · Derivative | 42,023 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025114 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,023 Underlying: Common Stock · 42,023 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC |
Coombe Gary ACEO - Grooming
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025114 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,905.9678 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:24 UTC |
Schulten AndreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 85,762 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025119 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,762 Underlying: Common Stock · 85,762 shares Expires 2034-09-29 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.